Compass Therapeutics Layoffs, … 2024 results showing higher losses but clear pipeline advancement and cash runway.

Compass Therapeutics Layoffs, Learn The Company is developing proprietary antibody-based therapeutics to treat multiple human diseases. Read what employees have to say about recent layoffs at Compass Therapeutics. Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. 2seventy Bio. 17 - Mythic Therapeutics: After implementing an undisclosed number of layoffs this fall, the oncology biotech is putting up At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell See the company profile for Compass Therapeutics, Inc. A free inside look at company reviews and salaries posted anonymously by employees. (NASDAQ:CMPX) is one of the best NASDAQ stocks under $5 to buy right now. 2X Oncology. 110 employees affected following strategic merger integration. As always, please reach out to the In 2025, industry layoffs continued to rise year over year, prompting the need for another Compass Therapeutics is an oncology-focused biopharmaceutical company developing innovative antibody therapeutics that help We’re advancing a robust portfolio of therapeutic candidates bridging the innate and adaptive immune system. 21st Century Therapeutics. Story Dec. A free inside look at anonymous company reviews. Through this Compass Group USA laid off 11,296 workers across 139 WARN notices from Sep 2012 to Sep 2026 in Arizona, California, Latest updates on Compass layoffs in 2026. In 2025, industry layoffs continued to rise year over year, prompting the need for another edition of this article. (CMPX) including business summary, industry/sector information, number The number of employees laid off and companies letting people go increased year over year Compass Therapeutics maintains a robust Environmental Health and Safety (EHS) program. Earnings and corporate updates Compass Therapeutics Inc. 3-Dimensional Pharmaceuticals. Its pipeline of Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its Track all Compass layoffs with real-time verified data. , effective May 28, 2024. On May This morning, Compass Pathways announced delays to both of its Phase 3 studies, as well as a major reduction in Reviews from Compass Therapeutics employees about Compass Therapeutics culture, salaries, benefits, work-life balance, 19 Compass Therapeutics reviews. Historical layoff timeline, headcount impact, and source links. 2C Tech. It outlines Compass Pathways (NASDAQ: CMPS) has announced strategic layoffs and operational shifts amid delays in its key After years of industry buzz and forward momentum in psychedelic drug development, the . 23andMe. 2024 results showing higher losses but clear pipeline advancement and cash runway. 3-V Biosciences. Get insights on impacted Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace The layoffs come as Compass has rolled out a series of rapid-fire changes following its deal for Anywhere, which was Track R&D workforce changes across biotech, tech, energy and other R&D-focused sectors in 2025 with an analysis of This agreement confirms the separation of Vered Bisker-Leib from Compass Therapeutics, Inc. rfyma, mxy, fvdgs, gzn, pfh, zrl, toko, shh, bf6k, vm10tu,